CVKD
NASDAQ · Pharmaceuticals
Cadrenal Therapeutics Inc
$6.35
-0.32 (-4.80%)
Open$6.88
Previous Close$6.67
Day High$7.27
Day Low$6.16
52W High$16.50
52W Low$4.21
Volume—
Avg Volume73.3K
Market Cap18.53M
P/E Ratio—
EPS$-6.70
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+166.9% upside
Current
$6.35
$6.35
Target
$16.95
$16.95
$12.65
$16.95 avg
$22.59
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 2.07M | 2.13M | 1.91M |
| Net Income | 662.5K | 666.1K | 461.6K |
| Profit Margin | 32.0% | 31.3% | 24.1% |
| EBITDA | 955.8K | 1.01M | 1.06M |
| Free Cash Flow | 570.9K | 515.8K | 427.8K |
| Rev Growth | +2.5% | +18.2% | +2.4% |
| Debt/Equity | 0.18 | 0.20 | 0.19 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |